A number of reports show that high endogenous, or therapeutic administration of human growth hormone (hGH) cause an increase of serum lipoprotein a, Lp(a). Being thrombogenic Lp(a) is an independent risk factor of atherosclerotic cardiovascular disease (ASCVD). Hence, it is hypothesized that the recently reported association between childhood hGH treatment and cardiovascular morbidity is probably due to the GH effect on Lp(a) synthesis. It is therefore suggested to determine serum Lp(a) levels before and during hGH treatment in children and adults.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ghir.2022.101503 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!